- Processing Solutions
- White Papers
- Buyer's Guide
ARUSHA, Tanzania — Tanzanian Pharmaceutical Industries Limited announced that a new plant will soon start production of anti-retrovira drugs (ARVs), East African Business Week reported.
Production of the drugs is expected to start next month and the plant will officially open on Dec. 1, World Aids Day.
The generic drug will cost local people living with HIV/Aids about $12 for their monthly dosages.“Our target is to ensure that Tanzania and East African countries are self-sufficient in the supply of the ARVs and other essential drugs in the region,” said Tanzanian Pharmaceutical Industries Limited CEO Ramadhan Madabida.